Kura Oncology grants inducement stock options for 128,250 shares to nine new hires

By Public Technologies
  • Kura Oncology granted nonstatutory stock options covering 128,250 shares to nine new employees on Oct. 1, 2026.
  • Options carry an exercise price of $10.65 per share, matching the Oct. 1 closing price.
  • Vesting spans four years: 25% after one year, then monthly over the next 36 months.
  • Awards were issued under the 2023 Inducement Option Plan, as amended.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Kura Oncology Inc. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202610020730PRIMZONEFULLFEED9838436) on October 02, 2026, and is solely responsible for the information contained therein.

Capital Com is an execution-only service provider. The present material must be regarded as marketing communication and should not be interpreted as investment research or investment advice. Any opinion that may be provided on this page does not constitute a recommendation by Capital Com or its agents. We do not make any representations or warranty on the accuracy or completeness of the information that is provided on this page. If you rely on the information on this page, then you do so entirely at your own risk